Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

被引：0

作者：

Shohei Eto

Yoko Nukui

Miyuki Tsumura

Yu Nakagama

Kenichi Kashimada

Yoko Mizoguchi

Takanori Utsumi

Maki Taniguchi

Fumiaki Sakura

Kosuke Noma

Yusuke Yoshida

Shinichiro Ohshimo

Shintaro Nagashima

Keisuke Okamoto

Akifumi Endo

Kohsuke Imai

Hirokazu Kanegane

Hidenori Ohnishi

Shintaro Hirata

Eiji Sugiyama

Nobuaki Shime

Masanori Ito

Hiroki Ohge

Yasutoshi Kido

Paul Bastard

Jean-Laurent Casanova

Osamu Ohara

Junko Tanaka

Tomohiro Morio

Satoshi Okada

机构：

[1] Hiroshima University Graduate School of Biomedical and Health Science,Department of Pediatrics

[2] Tokyo Medical and Dental University Hospital,Department of Infection Control and Prevention

[3] Kyoto Prefectural University of Medicine,Department of Infection Control and Laboratory Medicine

[4] Osaka City University,Department of Parasitology, Graduate School of Medicine

[5] Tokyo Medical and Dental University,Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences

[6] Hiroshima University Hospital,Department of Clinical Immunology and Rheumatology

[7] Hiroshima University Graduate School of Biomedical and Health Science,Department of Emergency and Critical Care Medicine

[8] Hiroshima University Graduate School of Biomedical and Health Sciences,Department of Epidemiology Infectious Disease Control and Prevention

[9] Tokyo Medical and Dental University Hospital,Clinical Research Center

[10] Tokyo Medical and Dental University,Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences

[11] Tokyo Medical and Dental University,Department of Child Health and Development

[12] Gifu University Graduate School of Medicine,Department of Pediatrics

[13] Emeritus Professor of Hiroshima University,Department of General Internal Medicine

[14] Hiroshima University Hospital,Department of Infectious Diseases

[15] Hiroshima University Hospital,Laboratory of Human Genetics of Infectious Diseases, Necker Branch

[16] INSERM U1163,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch

[17] Necker Hospital for Sick Children,Department of Applied Genomics

[18] University of Paris,undefined

[19] Imagine Institute,undefined

[20] The Rockefeller University,undefined

[21] Howard Hughes Medical Institute,undefined

[22] Kazusa DNA Research Institute,undefined

来源：

Journal of Clinical Immunology | 2022年 / 42卷

关键词：

COVID-19; Antibodies to type I IFNs; IFN-α2; IFN-ω; Neutralization assay; IFN-α2 concentration;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1360 / 1370

页数：10

共 50 条

[41] Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
Nicolas de Prost
Paul Bastard
Romain Arrestier
Slim Fourati
Mathieu Mahévas
Sonia Burrel
Karim Dorgham
Guy Gorochov
Yacine Tandjaoui-Lambiotte
Iname Azzaoui
Ignacio Fernandes
Alain Combes
Jean-Laurent Casanova
Armand Mekontso-Dessap
Charles-Edouard Luyt
[J]. Journal of Clinical Immunology, 2021, 41 : 536 - 544
[42] Autoantibodies in patients with diagnosis of COVID-19 and rheumatic diseases
Camacho Abarca, Evelyn Margarita
Llerena Flores, Gabriela Estefania
Tixi Berrones, Nathaly Silvana
Quishpe Chirau, Sara Marina
Quijosaca Cajilema, Luis Alberto
[J]. REVISTA CUBANA DE REUMATOLOGIA, 2021, 23 (01):
[43] Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens
Ulndreaj, Antigona
Wang, Mingyue
Misaghian, Salvia
Paone, Louis
Sigal, George B.
Stengelin, Martin
Campbell, Christopher
Van Nynatten, Logan R.
Soosaipillai, Antoninus
Ghorbani, Atefeh
Mathew, Anu
Fraser, Douglas D.
Diamandis, Eleftherios P.
Prassas, Ioannis
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (07) : 1116 - 1123
[44] The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Manry, Jeremy
Bastard, Paul
Gervais, Adrian
Le Voyer, Tom
Rosain, Jeremie
Philippot, Quentin
Michailidis, Eleftherios
Hoffmann, Hans-Heinrich
Eto, Shohei
Garcia-Prat, Marina
Bizien, Lucy
Parra-Martinez, Alba
Yang, Rui
Haljasmagi, Liis
Migaud, Melanie
Sarekannu, Karita
Maslovskaja, Julia
de Prost, Nicolas
Tandjaoui-Lambiotte, Yacine
Luyt, Charles-Edouard
Amador-Borrero, Blanca
Gaudet, Alexandre
Poissy, Julien
Morel, Pascal
Richard, Pascale
Cognasse, Fabrice
Troya, Jesus
Trouillet-Assant, Sophie
Belot, Alexandre
Saker, Kahina
Garcon, Pierre
Riviere, Jacques G.
Lagier, Jean-Christophe
Gentile, Stephanie
Rosen, Lindsey B.
Shaw, Elana
Morio, Tomohiro
Tanaka, Junko
Dalmau, David
Tharaux, Pierre-Louis
Sene, Damien
Stepanian, Alain
Megarbane, Bruno
Triantafyllia, Vasiliki
Fekkar, Arnaud
Heath, James R.
Franco, Jose Luis
Anaya, Juan-Manuel
Sole-Violan, Jordi
Imberti, Luisa
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (21)
[45] Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Ramasamy, Santhamani
Subbian, Selvakumar
[J]. CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (03)
[46] Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
Sinnberg, Tobias
Lichtensteiger, Christa
Ali, Omar Hasan
Pop, Oltin T.
Jochum, Ann-Kristin
Risch, Lorenz
Brugger, Silvio D.
Velic, Ana
Bomze, David
Kohler, Philipp
Vernazza, Pietro
Albrich, Werner C.
Kahlert, Christian R.
Abdou, Marie-Therese
Wyss, Nina
Hofmeister, Kathrin
Niessner, Heike
Zinner, Carl
Gilardi, Mara
Tzankov, Alexandar
Rocken, Martin
Dulovic, Alex
Shambat, Srikanth Mairpady
Ruetalo, Natalia
Buehler, Philipp K.
Scheier, Thomas C.
Jochum, Wolfram
Kern, Lukas
Henz, Samuel
Schneider, Tino
Kuster, Gabriela M.
Lampart, Maurin
Siegemund, Martin
Bingisser, Roland
Schindler, Michael
Schneiderhan-Marra, Nicole
Kalbacher, Hubert
McCoy, Kathy D.
Spengler, Werner
Brutsche, Martin H.
Macek, Boris
Twerenbold, Raphael
Penninger, Josef M.
Matter, Matthias S.
Flatz, Lukas
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (01) : 38 - 49
[47] Serum titer of neutralizing antibodies after COVID-19 vaccination in Japanese patients with inflammatory bowel disease
Sugaya, Takeshi
Takagi, Tomohisa
Uchiyama, Kazuhiko
Kajiwara-Kubota, Mariko
Asaeda, Kohei
Okumura, Keita
Inaba, Tohru
Naito, Yuji
Itoh, Yoshito
[J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2023, 72 (02) : 183 - 188
[48] Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis
Akbari, Abolfazl
Hadizadeh, Alireza
Amiri, Mahdi
Najafi, Neshat Najaf
Shahriari, Zahra
Jamialahmadi, Tannaz
Sahebkar, Amirhossein
[J]. JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2023, 7
[49] Maculopapular Rash in Japanese Patients with COVID-19
Seike, Issei
Kanamori, Hajime
Oshima, Kengo
Aoyagi, Tetsuji
[J]. INTERNAL MEDICINE, 2022, 61 (07) : 1113 - 1114
[50] A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients
Soltani-Zangbar, Mohammad Sadegh
Parhizkar, Forough
Ghaedi, Elham
Tarbiat, Ali
Motavalli, Roza
Alizadegan, Amin
Aghebati-Maleki, Leili
Rostamzadeh, Davoud
Yousefzadeh, Yousef
Jadideslam, Golamreza
Farid, Sima Shahmohammadi
Roshangar, Leila
Mahmoodpoor, Ata
Heris, Javad Ahmadian
Miahipour, Abolfazl
Yousefi, Mehdi
[J]. CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)

← 1 2 3 4 5 →